Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 6,613 | 4,084 | 4,016 | 3,922 |
| Marketable Securities | N/A | 2,979 | 2,502 | 3,334 | 3,515 |
| Receivables | N/A | 1,371 | 212 | 193 | 829 |
| TOTAL | $N/A | $10,963 | $6,798 | $7,543 | $8,266 |
| Non-Current Assets | |||||
| PPE Net | N/A | 357 | 375 | 424 | 454 |
| Investments And Advances | 0 | 0 | 533 | 545 | 533 |
| Other Non-Current Assets | 0 | 132 | 124 | 98 | 127 |
| TOTAL | $N/A | $489 | $1,032 | $1,067 | $1,114 |
| Total Assets | $N/A | $11,452 | $7,830 | $8,610 | $9,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 352 | 357 | 251 | 300 |
| TOTAL | $N/A | $352 | $357 | $251 | $300 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 3,008 | 811 | 958 | 1,299 |
| TOTAL | $N/A | $3,008 | $811 | $958 | $1,299 |
| Total Liabilities | $N/A | $3,360 | $1,168 | $1,209 | $1,599 |
| Shareholders' Equity | |||||
| Retained earnings | N/A | -27,725 | -23,112 | -22,998 | -21,860 |
| Other shareholders' equity | 0 | 149 | 375 | 677 | 662 |
| TOTAL | $N/A | $8,092 | $6,662 | $7,401 | $7,782 |
| Total Liabilities And Equity | $0 | $11,452 | $7,830 | $8,610 | $9,381 |